DongKook Life Science Co (303810.KQ) Stock Price
DongKook Life Science Co Price
Over the last 3 years DongKook Life Science Co grew revenue by 6.9% annually, reaching 126.57 B KRW. Earnings per share have grown at 26.9% per year over the last 3 years. For DongKook Life Science Co, the net margin of 6.8% is up versus 4.1% a few years ago.
DongKook Life Science Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
DongKook Life Science Co business model & stock analysis
Frequently asked questions about DongKook Life Science Co
Converted at the current exchange rate, the DongKook Life Science Co share trades at 1.42 EUR (2,110.00 KRW).
The expected revenue of DongKook Life Science Co is 163.92 B KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of DongKook Life Science Co is 10.37 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of DongKook Life Science Co is currently 6.51. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the DongKook Life Science Co stock.
The price-to-sales ratio (P/S) of DongKook Life Science Co is currently 0.41. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the DongKook Life Science Co stock.
The Eulerpool Quality Score for DongKook Life Science Co is 5/10.
The ISIN of DongKook Life Science Co is KR7303810006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of DongKook Life Science Co is 303810.KQ. The ticker symbol is used to trade DongKook Life Science Co shares on the stock exchange.
DongKook Life Science Co stock
DongKook Life Science Co Peer Group
All fundamentals and in-depth analysis of DongKook Life Science Co
Our stock analysis for DongKook Life Science Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DongKook Life Science Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.